Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Caiying Ye"'
Publikováno v:
Heliyon, Vol 9, Iss 9, Pp e20105- (2023)
Carboxyamidotriazole (CAI) was initially considered a non-cytotoxic anticancer agent. However, recently, pronounced anti-inflammatory properties of CAI have been reported. Rheumatoid arthritis (RA) is an autoimmune inflammatory disease characterized
Externí odkaz:
https://doaj.org/article/6e776d0722e14170b0279d7f69e453a5
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-14 (2019)
Abstract Background Cancer immunotherapy has generated significant excitement, mainly as a result of the development of immune checkpoint inhibitors. The blockade of PD-1 or its ligand with antibodies has resulted in impressive clinical efficacy. How
Externí odkaz:
https://doaj.org/article/8493cecc3b124436abe311419c181770
Publikováno v:
Clinical Rheumatology. 42:1635-1643
This study aimed to explore the changes of four major inflammasomes in adult-onset Still's disease (AOSD) and preliminarily evaluate the therapeutic effect of carboxyamidotriazole (CAI), which has previously been reported to have the significant anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f4b2d8afb69ea015bf131294eadbfad
https://doi.org/10.1007/s10067-022-06443-1
https://doi.org/10.1007/s10067-022-06443-1
Autor:
Danwei Wu, Caiying Ye, Zehao Guo, Duan Mengyuan, Juan Li, Xiaojuan Zhang, Lei Zhu, Dechang Zhang, Shan Lu, Yongting Zhou, Yicheng Wang, Rui Ju
Publikováno v:
Experimental and Therapeutic Medicine
Carboxyamidotriazole (CAI), originally developed as a non-cytotoxic anti-cancer drug, was shown to have anti-inflammatory activity according to recent studies in a number of animal models of inflammation. However, its mechanism of action has not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73ba04b0e81c644ac5d388c1b9197b5f
https://doi.org/10.3892/etm.2020.8889
https://doi.org/10.3892/etm.2020.8889
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-14 (2019)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Background Cancer immunotherapy has generated significant excitement, mainly as a result of the development of immune checkpoint inhibitors. The blockade of PD-1 or its ligand with antibodies has resulted in impressive clinical efficacy. However, a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c111b6406637fb2e9dcf133c96a3b1a0
http://link.springer.com/article/10.1186/s40425-019-0725-7
http://link.springer.com/article/10.1186/s40425-019-0725-7
Background: Some cancer cells may reshape their genetic make-up, adopt a special metabolism mode and undergo dormancy to endure drug attacks. Blocking survival signals in dormant cancer cells that survive a certain anticancer therapy and eradicating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7507d90d165a7c56b0cb66feecc44b33
https://doi.org/10.21203/rs.3.rs-66224/v1
https://doi.org/10.21203/rs.3.rs-66224/v1
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO1-4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bda5bfd477dea8dafab0039619321ecd
https://doi.org/10.1254/jpssuppl.wcp2018.0_po1-4-26
https://doi.org/10.1254/jpssuppl.wcp2018.0_po1-4-26
Autor:
Caiying Ye, Gou Wenfeng, Jingcheng Yu, Huiqiang Wei, Yongting Zhou, Ruixu Mu, Leyuan Chen, Wenbin Hou, Lei Zhu, Yiliang Li
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 53:128415
Inflammation and immunity are closely related to the occurrence and development of a variety of immune diseases. Although IL-1β has been identified as a key cytokine in many immune diseases, safe and specific small molecular IL-1β releasement inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::133866c52f9cb8638662bc4d60e27296
https://doi.org/10.1016/j.bmcl.2021.128415
https://doi.org/10.1016/j.bmcl.2021.128415
Autor:
Yanyong Liu, Jun Zhao, Zhanjun Yang, Pingping Zuo, Nan Yang, Shujie Fan, Junya Liu, Lu Feng, Caiying Ye, Mingyang Wang, Ji Zheng
Publikováno v:
Oncotarget
// Mingyang Wang 1 , Lu Feng 1 , Ji Zheng 1 , Junya Liu 1 , Shujie Fan 1 , Jun Zhao 2 , Nan Yang 1 , Yanyong Liu 1 , Zhanjun Yang 2 , Caiying Ye 1 and Pingping Zuo 1 1 Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47dec7ead04da0a28a3d26b8e32b2f61
https://doi.org/10.18632/oncotarget.18048
https://doi.org/10.18632/oncotarget.18048
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 390:423-433
Cancer cachexia is a complex disorder characterized by inflammatory responses, and it is associated with poor performance status and high mortality rate of cancer patients. Carboxyamidotriazole (CAI), a noncytotoxic chemotherapy agent, shows anti-inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6050aa7f72edc40bce382243386a4666
https://doi.org/10.1007/s00210-017-1345-8
https://doi.org/10.1007/s00210-017-1345-8